Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
F
|
First Majestic Silver Corp
XHAM:FMV
|
CA |
|
Holding Company ADMIE IPTO SA
OTC:HCAEF
|
GR |
|
H
|
Halma PLC
OTC:HLMAF
|
UK |
|
Telefonica SA
MAD:TEF
|
ES |
Wall St Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.86 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HCAT's stock price target?
Price Target
1.86
USD
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.86 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.
What is the Revenue forecast for Health Catalyst Inc?
Projected CAGR
-10%
Over the last 7 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is -10%.
What is the Gross Profit forecast for Health Catalyst Inc?
Projected CAGR
-7%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is -7%.